Ftse Mib
33.707,21
-0,38%
DAX
18.177,62
-0,90%
S&P 500
5.469,30
0,39%
NASDAQ
17.717,65
1,26%
Bitcoin
62.058,24
0,40%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSXV Kane Biotech Inc (KNE) Kane Biotech Inc (KNE) Notizie

Kane Biotech Inc

KNE
0,145
0,00 (0,00%)
25 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: TSX Venture
Tipo: Azione
Valuta: CAD

Ultime notizie

Data Ora Fonte Titolo
25/6/202414:30GLOBEKane Biotech Signs Worldwide License Agreement with..
23/5/202422:15GLOBEKane Biotech Announces First Quarter 2024 Financial Results
16/5/202414:00GLOBEKane Biotech to Release First Quarter 2024 Financial Results..
15/5/202414:00GLOBEKane Biotech Expands its Wound Care Portfolio with Patented..
16/4/202415:15GLOBEKane Biotech to Host Investor Webinar
15/4/202417:07APSDual Listed Biotech Firm Achieves Sale of Animal Health..
15/4/202415:15GLOBEKane Biotech Announces Closing of the Sale of STEM Animal..
11/4/202416:03PRNCAL'Organisme canadien de réglementation des investissements..
11/4/202416:00PRNCACanadian Investment Regulatory Organization Trade Resumption..
11/4/202415:45GLOBEKane Biotech Announces Agreement in Principle for the Sale..
11/4/202415:07PRNCASuspension de la négociation par l'Organisme canadien de..
11/4/202415:04PRNCACanadian Investment Regulatory Organization Trading Halt -..
26/3/202421:05GLOBEKane Biotech Announces Fourth Quarter and Full Year 2023..
20/3/202413:30GLOBEKane Biotech Extends Exclusivity Period on its Offer for its..
19/3/202421:10GLOBEKane Biotech to Release Fourth Quarter and Full Year 2023..
08/3/202415:00GLOBEKane Biotech Receives Bioscience Association Manitoba..
22/2/202414:00GLOBEDr. Robert Huizinga Elected to the Kane Biotech Board and..
31/1/202414:30GLOBEKane Biotech Files New Patent on revyve™ Antimicrobial Wound..
25/1/202418:03GLOBEKane Biotech to Present its revyve™ Antimicrobial Wound Gel..
18/1/202422:30GLOBEKane Biotech Announces Special Meeting of Shareholders
29/12/202320:33GLOBEKane Biotech Announces Correction to Press Release
28/12/202322:05GLOBEKane Biotech Announces Amendment to its Credit Facility
20/12/202314:29GLOBEKane Biotech Receives Offer for its Interest in STEM Animal..
28/11/202322:05GLOBEKane Biotech Announces Improved Third Quarter 2023 Financial..
21/11/202313:45GLOBEKane Biotech to Release Third Quarter 2023 Financial Results..
16/11/202319:45GLOBEKane Biotech Strengthens Board with Biotech Executive
02/11/202316:48GLOBEKane Biotech and ProgenaCare Global Launch Newly Rebranded..
25/10/202313:45GLOBEKane Biotech to Exhibit at Symposium on Advanced Wound Care..
12/9/202313:45GLOBEKane Biotech Announces Closing of Fully Subscribed Private..
29/8/202322:29GLOBEKane Biotech Announces Second Quarter 2023 Financial Results
22/8/202313:30GLOBEKane Biotech to Release Second Quarter 2023 Financial..
03/8/202313:45GLOBEKane Biotech Announces Private Placement Offering and..
02/8/202313:30GLOBEKane Biotech Engages Research Capital to Conduct Strategic..
Apertura: 0,14 Min: 0,135 Max: 0,145
Chiusura: 0,145

La tua Cronologia

TSXV
KNE
Kane Biotech
COIN
MDTEUR
Measurable Data Token
TSXV
GNT.H
Gentor Resources
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network